Serex, Plasma-Processing Firm, Plans Sale of Stock
Serex International, a Van Nuys company that acquires and resells human blood plasma, plans to go public by selling 500,000 common shares of stock.
In a filing with the Securities and Exchange Commission, Serex proposed selling the stock for $5 a share, or a total of $2.5 million. Excluding underwriting commissions and other costs, the offering would raise $2.13 million for Serex.
Serex acquires and processes blood from people who had infections or diseases that produce “rare and special” antibodies. Serex’s customers further treat the antibodies to create therapeutic products for other patients.
Serex said it earned $158,835 on sales of $1.29 million in its fiscal year that ended May 31.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
